Nurse Practitioner, Family · Johnson City, NY
NPI
1265661490
Since 2009
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
40 Arch St
Johnson City, NY, 13790
Phone (607) 763-6092
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
865 services
Medicare patients, 2024
215
Average age 71
Drug cost, 2024
$4.9M
7,642 prescriptions
Company payments, 2025
$1,041
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stacy L Congdon was code 99214 (office e&m - established), 337 times for 175 patients. In total Stacy L Congdon billed 865 services in 7 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-11-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 337 | 175 | $55.96 | $19K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 218 | 132 | $10.09 | $2,200 |
| 95251 Test - Miscellaneous | Office | 176 | 86 | $20.95 | $3,688 |
| 99213 Office E&M - Established | Office | 115 | 83 | $37.94 | $4,363 |
By year: 2022 $30K for 678 services; 2023 $28K for 629 services; 2024 $30K for 865 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stacy L Congdon prescribed most often to Medicare patients was Ozempic (Semaglutide), with 652 prescriptions and refills. In total Stacy L Congdon wrote 7,642 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 652 | 1,327 | 173 | $1.2M |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 492 | 1,242 | 178 | $99K |
| Mounjaro Tirzepatide | 421 | 464 | 102 | $480K |
| Metformin Hcl Generic | 370 | 972 | 111 | $2,827 |
| Humalog Kwikpen U-100 Insulin Lispro | 293 | 602 | 94 | $167K |
| Novolog Flexpen Insulin Aspart | 273 | 589 | 104 | $131K |
| Metformin Hcl Er Metformin Hcl | 231 | 654 | 81 | $4,079 |
| Jardiance Empagliflozin | 231 | 633 | 74 | $355K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 227 | 552 | 98 | $26K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 225 | 522 | 90 | $26K |
| Trulicity Dulaglutide | 221 | 350 | 50 | $335K |
| Levothyroxine Sodium Generic | 195 | 518 | 72 | $3,175 |
| Glimepiride Generic | 183 | 519 | 58 | $1,951 |
| Tresiba Flextouch U-100 Insulin Degludec | 183 | 475 | 62 | $167K |
| Farxiga Dapagliflozin Propanediol | 168 | 432 | 54 | $233K |
Brand drugs: 4,385 claims; generic drugs: 2,044 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stacy L Congdon $1,041 ($1,041 in general payments such as food, travel and fees) from 23 companies. The largest payer was Lilly USA, LLC with $167.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 8 | $167 |
| Novo Nordisk Inc NVO | 6 | $133 |
| Abbott Laboratories ABT | 5 | $117 |
| Inspire Medical Systems, Inc. INSP | 4 | $89.27 |
| Dexcom, Inc. DXCM | 3 | $63.45 |
| Antares Pharma, Inc. | 3 | $58.15 |
| Tandem Diabetes Care, Inc. TNDM | 2 | $57.11 |
| Recordati_rare_diseases_inc. | 2 | $46.15 |
| Radius Health, Inc. | 1 | $33.05 |
| Ascendis Pharma Endocrinology Inc ASND | 1 | $29.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.